V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320005092 | 320003469 | 1.74 | 78 | Palliative (P) | 2017-08-28 | 2017-09-10 | GemCarbo Days 1+8 | N | N | 320015493 | GEMCARBO |
| 320005093 | 320003469 | 1.6 | 70 | Adjuvant (A) | 2013-11-07 | 2013-11-09 | EW EuroEwing 2012 Arm B IE | N | N | 320015493 | TRIAL |
| 320005094 | 320003470 | 1.53 | 62 | null | null | 2016-05-29 | Cisplatin 100 + RT(H&N) 1 day | N | N | 320015517 | CISPLATIN + RT |
| 320005095 | 320003471 | 1.61 | 58.9 | null | 2016-08-15 | 2016-08-28 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 320015534 | LIPOSOMAL DOXORUBICIN |
| 320005096 | 320003471 | 1.79 | 96 | Palliative (P) | 2014-10-14 | 2015-04-15 | CISPLATIN + FLUOROURACIL | N | Y | 320015534 | CISPLATIN + FLUOROURACIL |
| 320005097 | 320007281 | 1.75 | 76.7 | Adjuvant (A) | 2015-12-14 | 2016-01-10 | null | 02 | N | 320015543 | NOT MATCHED |
| 320005098 | 320007281 | 1.82 | 107 | null | 2015-03-22 | 2015-04-26 | Cisplatin | N | N | 320015543 | CISPLATIN |
| 320005099 | 320005577 | 1.71 | 70 | null | 2017-05-18 | 2017-05-19 | Trial Unspecified | 2 | null | 320015564 | TRIAL |
| 320005100 | 320003473 | 1.87 | 77.8 | Palliative (P) | null | 2018-08-19 | Liposomal Doxorubicin (Caelyx) | 02 | N | 320015567 | LIPOSOMAL DOXORUBICIN |
| 320005101 | 320003473 | 1.75 | 78.55 | Palliative (P) | 2016-11-22 | 2016-12-14 | Liposomal Doxorubicin (Caelyx) | 1 | N | 320015567 | LIPOSOMAL DOXORUBICIN |
| 320005102 | 320003473 | 1.64 | 107 | Palliative (P) | 2015-11-17 | 2015-11-20 | CISPLATIN + FLUOROURACIL | N | N | 320015567 | CISPLATIN + FLUOROURACIL |
| 320005103 | 320003474 | 1.59 | 50 | Palliative (P) | 2018-03-13 | 2018-03-27 | null | 2 | Y | 320015586 | NOT MATCHED |
| 320005104 | 320003477 | 1.6 | 51.6 | null | 2013-03-25 | 2013-04-21 | Cisplatin + Radiotherapy | N | N | 320015587 | CISPLATIN + RT |
| 320005105 | 320003478 | 1.67 | 78 | Adjuvant (A) | 2017-04-22 | 2017-07-09 | Cisplatin 7 day | N | N | 320015588 | CISPLATIN |
| 320005106 | 320003478 | 1.78 | 76 | Palliative (P) | 2018-01-06 | 2018-01-06 | Carboplatin + Liposomal Doxorubicin | 2 | Y | 320015588 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005107 | 320003478 | 1.52 | 0 | Curative (C) | null | 2016-02-15 | CISPLATIN + RT | Y | null | 320015588 | CISPLATIN + RT |
| 320005108 | 320007283 | 1.7 | 118 | Palliative (P) | 2018-10-07 | 2018-11-09 | Carboplatin + Liposomal Doxorubicin | 02 | Y | 320015599 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005109 | 320007283 | 1.69 | 82.2 | Palliative (P) | 2015-06-24 | 2015-06-24 | Trial Unspecified | 02 | N | 320015599 | TRIAL |
| 320005110 | 320003479 | 1.83 | 95 | Adjuvant (A) | 2016-01-07 | 2016-01-29 | Cisplatin + Radiotherapy | N | N | 320015612 | CISPLATIN + RT |
| 320005111 | 320003480 | 0 | 66 | Palliative (P) | 2017-09-17 | 2017-12-11 | EW EuroEwing 2012 Arm B VDC | 2 | N | 320015612 | TRIAL |
| 320005112 | 320003480 | 1.75 | null | Palliative (P) | null | 2014-01-17 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 320015612 | CISPLATIN + FLUOROURACIL |
| 320005113 | 320003480 | 1.6 | null | Palliative (P) | 2016-12-05 | 2016-12-19 | null | N | N | 320015612 | NOT MATCHED |
| 320005114 | 320003480 | 1.61 | null | Neo-adjuvant (N) | 2016-09-29 | 2016-10-20 | Cisplatin +Fluorouracil (3 wk) | N | N | 320015612 | CISPLATIN + FLUOROURACIL |
| 320005115 | 320007459 | 1.78 | 95 | Curative (C) | 2015-10-28 | 2015-12-09 | Cisplatin + Radiotherapy | N | N | 320015645 | CISPLATIN + RT |
| 320005116 | 320003481 | 1.56 | 63.8 | Curative (C) | 2018-07-05 | 2018-07-12 | Trial Unspecified | 02 | N | 320015652 | TRIAL |
| 320005117 | 320003482 | 1.65 | 81 | Adjuvant (A) | 2014-06-22 | 2014-07-04 | Cisplatin + Radiotherapy | 2 | Y | 320015652 | CISPLATIN + RT |
| 320005118 | 320003483 | 1.87 | 79.7 | Neo-adjuvant (N) | 2016-09-23 | 2016-09-23 | GemCarbo Days 1+8 | 02 | Y | 320015662 | GEMCARBO |
| 320005119 | 320003483 | 1.74 | 83 | Adjuvant (A) | 2013-02-27 | 2013-04-14 | Cisplatin 100 + RT(H&N) 1 day | 02 | Y | 320015662 | CISPLATIN + RT |
| 320005120 | 320003484 | 1.7 | 78 | Curative (C) | 2018-01-09 | 2018-01-10 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 320015665 | CISPLATIN + RT |
| 320005121 | 320003486 | 1.89 | 53.6 | Curative (C) | 2015-07-19 | 2015-11-08 | Cisplatin + Radiotherapy | 02 | N | 320015671 | CISPLATIN + RT |
| 320005122 | 320005587 | -1 | 63.9 | Palliative (P) | 2017-10-27 | 2017-10-30 | Trial Unspecified | 02 | N | 320015672 | TRIAL |
| 320005123 | 320003488 | 1.6 | 70 | Palliative (P) | 2018-01-15 | 2018-05-10 | CISPLATIN + FLUOROURACIL | 02 | Y | 320015674 | CISPLATIN + FLUOROURACIL |
| 320005124 | 320003489 | 1.6 | 117 | Curative (C) | 2014-09-16 | 2014-09-20 | Cetuximab 7 day (>Cycle 2) | 2 | Y | 320015677 | CETUXIMAB |
| 320005125 | 320003490 | 1.56 | 53 | Palliative (P) | 2015-07-09 | 2015-07-09 | Cetuximab 7 day (>Cycle 2) | 02 | N | 320015687 | CETUXIMAB |
| 320005126 | 320003491 | 1.74 | 74.6 | Curative (C) | null | 2018-10-17 | Cisplatin 100 + RT(H&N) 1 day | N | N | 320015689 | CISPLATIN + RT |
| 320005127 | 320003492 | 1.69 | 86.2 | Palliative (P) | 2017-12-27 | 2017-12-28 | GemCarbo Days 1+8 | N | N | 320015696 | GEMCARBO |
| 320005128 | 320003493 | 0 | 94.8 | Adjuvant (A) | 2014-12-26 | 2014-12-28 | Cisplatin 100 + RT(H&N) 1 day | N | N | 320015699 | CISPLATIN + RT |
| 320005129 | 320003493 | 1.56 | null | Palliative (P) | 2015-09-10 | 2015-09-10 | CARBOPLATIN + GEMCITABINE | N | null | 320015699 | GEMCARBO |
| 320005130 | 320003494 | 1.58 | 73 | Not known (9) | 2016-07-05 | 2016-07-07 | CISPLATIN + FLUOROURACIL | N | N | 320015705 | CISPLATIN + FLUOROURACIL |
| 320005131 | 320003494 | 1.68 | 100.9 | Curative (C) | 2015-02-21 | 2015-03-24 | Cisplatin + Radiotherapy | N | N | 320015705 | CISPLATIN + RT |
| 320005132 | 320003495 | 1.77 | null | Neo-adjuvant (N) | 2016-12-21 | 2016-12-21 | Trial Unspecified | 02 | N | 320015707 | TRIAL |
| 320005133 | 320003495 | 1.61 | 58.2 | Palliative (P) | 2018-12-13 | 2018-12-13 | CISPLATIN + FLUOROURACIL | N | N | 320015707 | CISPLATIN + FLUOROURACIL |
| 320005134 | 320007066 | 0 | null | Palliative (P) | 2018-02-23 | 2018-03-05 | Liposomal Doxorubicin 40mg/m2 | N | N | 320015712 | LIPOSOMAL DOXORUBICIN |
| 320005135 | 320003496 | 1.68 | 90.5 | Palliative (P) | 2016-12-05 | 2016-12-11 | CARBOPLATIN + GEMCITABINE | 02 | N | 320015725 | GEMCARBO |
| 320005136 | 320003497 | 1.94 | 106.2 | Palliative (P) | 2013-07-15 | 2014-09-24 | Carboplatin + Liposomal Doxorubicin | N | N | 320015728 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005137 | 320003499 | 1.62 | 53.45 | Palliative (P) | null | 2015-07-04 | GemCarbo Days 1+8 | N | N | 320015734 | GEMCARBO |
| 320005138 | 320003499 | 1.81 | 82 | Curative (C) | 2013-10-26 | 2013-11-24 | Cisplatin 100 + RT(H&N) 1 day | null | null | 320015734 | CISPLATIN + RT |
| 320005139 | 320003500 | 1.7 | 64.2 | null | 2017-02-20 | 2017-02-20 | Cisplatin + Radiotherapy | 02 | N | 320015742 | CISPLATIN + RT |
| 320005140 | 320003501 | 1.84 | 71 | Curative (C) | 2015-02-02 | 2015-02-13 | Cisplatin + Radiotherapy | 02 | N | 320015746 | CISPLATIN + RT |
| 320005141 | 320003502 | 1.71 | 81.3 | Palliative (P) | 2016-03-18 | 2016-04-06 | GEMCARBO | N | null | 320015747 | GEMCARBO |